“When we talk about access, what I look at is going back to the basics, at the capacity and capability of people on the ground. Do they know the disease? Can they diagnose? Do they know what to prescribe?” Racey Muchilwa, Head of Africa Cluster, Novartis #AccessinAction t.co/37NGhj4aOS